Yes.
And CSO responsible for running preclinical trials.
Of course they should talk. But the final responsibility for a clinical trial lies with the CMO. So, going forward, Michelle is the key person for the trials.
Ann: Race Board and Management Team Changes, page-430
-
- There are more pages in this discussion • 21 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.50 |
Change
0.035(2.39%) |
Mkt cap ! $249.7M | |||
| Open | High | Low | Value | Volume |
| $1.50 | $1.50 | $1.50 | $42.97K | 28.64K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2070 | $1.49 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.50 | 525 | 2 |
View Market Depth
| Last trade - 10.25am 04/11/2024 (20 minute delay) ? |
| RAC (ASX) Chart |